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tiveness ratios for stage 5 without and with CPEs were Rp7,870,936.19 and
Rp7,137,874.93, respectively. ICERs was Rp1,486,786.41 for CKD stage 4 and
Rp234,898.33 for CKD stage 5. CONCLUSIONS: Treatment of CKD stage 4 and 5 with
CPE was more effective and cost-effective compared to those without CPE. The
ICERs indicated that extra costs were required to increase life saved in both stages.
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OBJECTIVES: To compare health-related quality-of-life (HRQoL) in patients on hemo-
dialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) in a tertiary hos-
pital in China.METHODS: From September 2004 to January 2005, adult patients on
HD or CAPD for at least 6 months were recruited with clinical and HRQoL data
collected by medical records review and patient survey. Patients’ HRQoL was as-
sessed by KDQOL-SF including SF-36 as the generic and 11 disease-specific do-
mains with higher scores indicating better HRQoL. RESULTS: Eighty-six patients
[50 on CAPD and 36 on standard HD (3x4-hour weekly)] were included for the
analysis, with 55% male and a mean age of 57.715.6 years. No differences were
found in age, sex, education, payment method, income, originating disease, hae-
moglobin level, and dialysis time between HD and CAPD. CAPD patients had a
higher score (SD) compared to HD patients for Effects of Kidney Disease (EKD:
55.1(15.8) vs. 40.8(10.2), p .0001), Symptom/Problem List (SPL: 67.8(12.6) vs.
59.5(7.7), p 0.0005), Quality of Social Interaction (QSI: 65.0(13.9) vs. 58.1(9.1), p
0.006) and Patient Satisfaction (PS: 70.0(12.1) vs. 60.7(13.3), p0.001). CAPD group vs.
HDalsohadhigher scoresonBodyPain (BP: 60.2(14.2) vs. 45.4(18.1), p 0.0003), General
Health (GH: 33.6 (15.1) vs. 26.7(11.7), p0.03), Role-Emotional (RE: 61.4(25.5) vs.
41.7(33.2), p0.002) and Mental Health (MH: 67.3(14.0) vs. 55.3(19.4), p 0.002) from
SF-36 assessment. Controlling for key factors/covariates, CAPD patients still showed
better scores comparing toHDpatients inEKD,SPL, PS, BP,REandMH.Olderage, lower
haemoglobin level and originating disease of hypertension were shown to be associ-
ated with lower scores of certain dimensions compared to their counterparts,
respectively. CONCLUSIONS: CAPD patients showed better HRQoL in EKD, SPL,
PS, BP, RE and MH than HD patients in this study population. The findings may
help understand HRQoL burden and influential factors among dialysis patients.
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OBJECTIVES: To obtain availability and assess the quality of existing evidence on
effectiveness of poliglecaprone, polydioxanone and polyglactin-910 when used in
different abdominal layers suturing.METHODS: Studies were identified by means
of systematic search in MEDLINE, EMBASE and CENTRAL databases. Supplemen-
tary search for ongoing trials was also conducted. All studies published since 2000
and evaluating at least one of the selected interventions, with exception to case
reports and cross sectional studies, were regarded as appropriate. Data selection
was performed independently by two reviewers. Each study was characterized in
detail according to predefined categories. Quality of those trials was assessed using
Jadad or NOS scale depending on the type of the study. All information were sub-
sequently exploited to create Dynamic Literature Catalogue – a novel toll for quick
and efficient data reviewing. RESULTS: Among 119 positions qualified for full text
analysis 40 publications met our inclusion criteria. Majority of those studies (n 
30) were designed as RCTs, eight were non-randomized comparative studies, one
was conducted in a single arm scheme. Sixteen trials had their center location
situated in Asia region. Twenty-six studies were considered as large trials includ-
ing  100 patients. Target population comprised mainly adult patients. Main re-
ported outcomes were wound infection or other complications, healing and cos-
mesis effects and patients satisfaction. All data extracted from publication were
included in the Dynamic Literature Catalogue. To make reviewing of all selected
information more efficient, we categorized them into several domains distin-
guished in accordance with PICO scheme. Appropriate filters allowing for quick
data selection and analyzing were used in each domain. CONCLUSIONS: There is
numerous of available evidence on using poliglecaprone, polydioxanone and
polyglactin-910 in different abdominal layers suturing. We showed that reviewing
and analyzing this data can be simplified and adjusted to different area of interest
when Dynamic Literature Catalogue is used.
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OBJECTIVES: Although the WHO fracture risk assessment tool (FRAXTM) has been
developed, its algorithm is unpublished and not necessarily available for economic
evaluations. The purpose of this studywas to develop a health economicmodel for
assessing the cost-effectiveness of osteoporosis treatment in postmenopausal
womenwith rheumatoid arthritis, who have received combination therapy includ-
ing corticosteroids in Japan.METHODS:We constructed risk equations for age and
bone mineral density (BMD)-specific fracture applying a series of methods pro-
posed by De Laet CE et al (1997) to epidemiological data unique to Japanese. A state
transition model with six health states (no fracture, post-vertebral fracture, post-
hip fracture, post-vertebral and hip fracture, bedridden, and death) was developed
to predict a ten year probability of hip fracture and the ten year probability of a
major osteoporoetic fracture. Model validity was verified by comparison of the
predicted fracture probabilities by different combination of age (55 to 65 years) and
BMD (T-score -1.5 to -2.5) between the developed model and FRAX. RESULTS: Indi-
vidual simulation for 1,000womenaged 55, 60 and 65 years resulted in the expected
life years of 31.3 to 32.3, 27.1 to 27.9 and 22.9 to 23.6, respectively, about the same as
in national life table in Japan. The predicted probability of hip fracture in women
with T-score -1.5, -2.0 and -2.5were ranged to 0.8 to 1.4%, 1.4 to 2.5% and 2.9 to 5.1%,
respectively, and consistent with those of FRAX as follows: 0.8 to 1.9%, 1.5 to 3.1%
and 2.8 to 5.2%, respectively. As expected, our model had the tendency to slightly
underestimate the probability of a major fracture because the model did not con-
sider an occurrence of humerus fracture and wrist fracture. CONCLUSIONS: The
model newly developed was validated and helpful for determining the cost-effec-
tive treatment thresholds for corticosteroid-induced osteoporosis in postmeno-
pausal women with rheumatoid arthritis.
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OBJECTIVES: To develop standard unit costs of medical services provided by dif-
ferent health facilities, cost of patients coming for treatments, and reference values
used in the economic evaluation.METHODS: The project was conducted as a num-
ber of sub-projects. Analysis of unit cost of medical services was conducted in 5
hospitals employing the relative value unit method. Cost of health center services
was calculated in 19 health centers employing standard costing andmicro-costing
methods. Cost of pharmaceutical services was analysed in 11 hospitals. Logistics
cost of vaccines under the national vaccination program covered the supply chain
from the central supplier to provincial health offices. Cost of patients coming to
have treatments was collected by interviewing 900 patients from 6 health centers,
3 district hospitals and 3 provincial/regional hospitals. Reference values were ob-
tained from documentary research. RESULTS: The results were published in a
book, and can be accessed via the Health Intervention and Technology Assessment
(HITAP) website (http://db.hitap.net/). They are composed of 3091 items of hospital
medical services in two categories of hospitals: district and provincial/regional
hospitals. Services of hospital pharmacy departments, and health services pro-
vided by health centers, include 9 and 68 items, respectively. Logistics cost of
vaccines is presented as cost per dose of the vaccine supplied. Cost of patients is
composed of distance, time, transportation cost and meal cost. Reference values
are useful years of capital assets (i.e. buildings, vehicles, furniture and equipment),
minimumwage, and gross domestic product per capita. CONCLUSIONS: This stan-
dard cost menu and reference values should make economic evaluations faster
and more convenient. This is the first standard cost menu to be developed for
Thailand. Some limitations exist, whichwill be improved upon in the next revision.
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OBJECTIVES: Some insist that productivity loss should not be included in costs
when using quality-adjusted life year (QALY) because QALY also reflects the influ-
ence of work loss and thus results in “double counting.” “Double counting” of QALY
and productivity loss is a controversial issue, particularly given the lack of empir-
ical data addressing the influence of income reduction on utility scores.METHODS:
In this study, we performed a web-based, large-sample survey to address the issue
of double counting. To determine the influence of income reduction on utility
scores, we obtained utility scores of eight health states with three instruction
types: a) no instruction; b) instructed to consider income reduction; and c) in-
structed not to consider income reduction (compensated). Respondents were ran-
domly sampled from the on-line panel adjusted by age and sex. Theywere asked to
evaluate one of 24 patterns by both standard gamble (SG) and time trade-off (TTO)
methods. RESULTS: A total of 6551 respondents completed the questionnaire. Re-
spondent demographics were similar to the Japanese general population. First,
despite the lack of instruction on income reduction, many respondents spontane-
ously assumed lost income. The proportion tended to be higher when considering
more severe health states. Second, the degree of assumed income reduction was
related to utility scores. For a 10% income reduction, respondents assumed a 0.02 to
0.04 decrease in utility score (both SG and TTO methods). Third, utility scores did
not change significantly, even when the decrease in income was compensated. In
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